ASYMMETRIC DIMETHYLARGININE (ADMA) IN ENDOCRINE DISEASES

被引：0

作者：

Altinova, Alev Eroglu ^{[1
]}

Arslan, Metin ^{[2
]}

机构：

[1] Elazig Egitim & Arastirma Hastanesi, Endokrinol & Metab Bolumu, Elazig, Turkey

[2] Gazi Univ, Tip Fak, Endokrinol Metab Anabilim Dali, Ankara, Turkey

来源：

MARMARA MEDICAL JOURNAL | 2009年 / 22卷 / 01期

关键词：

ADMA; NO; Endocrine diseases; Cardiovascular risk;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Asymmetric dimethylarginine (ADMA) is the major inhibitor of nitric oxide biosynthesis in humans. Recent reports have demonstrated that elevated plasma ADMA levels are associated with endothelial dysfunction and increased atherogenesis. Elevated ADMA levels, which contribute to an increased cardiovascular risk, have been reported in several endocrine diseases. The role of ADMA in various endocrine diseases such as diabetes mellitus, obesity and thyroid dysfunction are discussed in this review.

引用

页码：80 / 84

页数：5

共 38 条

[1] Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].

Achan, V ;

Broadhead, M ;

Malaki, M ;

Whitley, G ;

Leiper, J ;

MacAllister, R ;

Vallance, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459

[2] Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations [J].

Altinova, Alev E. ;

Arslan, Metin ;

Sepici-Dincel, Aylin ;

Akturk, Mujde ;

Altan, Nilgun ;

Toruner, Fusun B. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05) :1881-1885

[3] Asymmetric dimethylarginine levels in thyroid diseases [J].

Arikan, E. ;

Karadag, C. H. ;

Guldiken, S. .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (03) :186-191

[4] Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].

Böger, RH ;

Bode-Böger, SM ;

Szuba, A ;

Tsao, PS ;

Chan, JR ;

Tangphao, O ;

Blaschke, TF ;

Cooke, JP .

CIRCULATION, 1998, 98 (18) :1842-1847

[5] LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases [J].

Böger, RH ;

Sydow, K ;

Borlak, J ;

Thum, T ;

Lenzen, H ;

Schubert, B ;

Tsikas, D ;

Bode-Böger, SM .

CIRCULATION RESEARCH, 2000, 87 (02) :99-105

[6]

Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173

[7] The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [J].

Böger, RH .

CARDIOVASCULAR RESEARCH, 2003, 59 (04) :824-833

[8]

CALVER A, 1993, J HUM HYPERTENS, V7, P193

[9] Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? [J].

Chan, NN ;

Chan, JCN .

DIABETOLOGIA, 2002, 45 (12) :1609-1616

[10]

Charitidou C, 2007, ATHEROSCLEROSIS

← 1 2 3 4 →